Literature DB >> 17549011

Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene.

Shoichi Sasaki1, Makiko Nagai, Masashi Aoki, Takashi Komori, Yasuto Itoyama, Makoto Iwata.   

Abstract

Human familial amyotrophic lateral sclerosis with an H46R mutant Cu/Zn superoxide dismutase (SOD1) gene is characterized by initial muscle weakness and atrophy in the legs and a very long-term clinical course (approximately 15 years). Transgenic mice with this mutation generated in our laboratory occasionally showed aggregates in the anterior horns and axonal degeneration in all white matter sections of the spinal cord on plastic sections at the presymptomatic stages (12 and 16 weeks old), although conventional staining revealed no pathologic changes. At the symptomatic stages (20 and 24 weeks), loss of anterior horn neurons was observed. On plastic sections, aggregates were frequently seen not only in the anterior horns but also in the posterior horns and in all sections of white matter. Degenerated fibers were observed in the anterior and posterior roots as well as in white matter. Electron and immunoelectron microscopic observation revealed human SOD1- and ubiquitin-positive aggregates consisting of intermediate filaments in the anterior horn even from an early presymptomatic stage. Thus, H46R mutant SOD1 transgenic mice are characterized by widespread pathologic changes of the spinal cord that extend beyond the motor system, including many aggregates lacking vacuoles. The close pathologic similarity makes this animal model suitable for the investigation of human familial amyotrophic lateral sclerosis with the mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549011     DOI: 10.1097/01.jnen.0000263868.84188.3b

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Structures of mouse SOD1 and human/mouse SOD1 chimeras.

Authors:  Sai V Seetharaman; Alexander B Taylor; Stephen Holloway; P John Hart
Journal:  Arch Biochem Biophys       Date:  2010-08-19       Impact factor: 4.013

Review 2.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

3.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

4.  Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

Authors:  Shinji Hadano; Asako Otomo; Ryota Kunita; Kyoko Suzuki-Utsunomiya; Akira Akatsuka; Masato Koike; Masashi Aoki; Yasuo Uchiyama; Yasuto Itoyama; Joh-E Ikeda
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

5.  An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS.

Authors:  Masamitsu Shimazawa; Hirotaka Tanaka; Yasushi Ito; Nobutaka Morimoto; Kazuhiro Tsuruma; Michinori Kadokura; Shigeki Tamura; Teruyoshi Inoue; Mitsunori Yamada; Hitoshi Takahashi; Hitoshi Warita; Masashi Aoki; Hideaki Hara
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

6.  Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.

Authors:  Mercedes Prudencio; David R Borchelt
Journal:  Mol Neurodegener       Date:  2011-11-17       Impact factor: 14.195

7.  Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.

Authors:  Lei Pan; Yasuhiro Yoshii; Asako Otomo; Haruko Ogawa; Yasuo Iwasaki; Hui-Fang Shang; Shinji Hadano
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model.

Authors:  Shun Mitsui; Asako Otomo; Masahisa Nozaki; Suzuka Ono; Kai Sato; Ryohei Shirakawa; Hiroaki Adachi; Masashi Aoki; Gen Sobue; Hui-Fang Shang; Shinji Hadano
Journal:  Mol Brain       Date:  2018-05-29       Impact factor: 4.041

9.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

10.  SOD-1 Variants in Amyotrophic Lateral Sclerosis: Systematic Re-Evaluation According to ACMG-AMP Guidelines.

Authors:  Paola Ruffo; Benedetta Perrone; Francesca Luisa Conforti
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.